These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2140899)

  • 21. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
    Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ; Guan XM; Shulgin AT
    Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantioselective gas chromatographic assay with electron-capture detection for dl-fenfluramine and dl-norfenfluramine in plasma.
    Srinivas NR; Hubbard JW; Cooper JK; Midha KK
    J Chromatogr; 1988 Dec; 433():105-17. PubMed ID: 3235539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
    Clausing P; Newport GD; Bowyer JF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
    Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
    Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation.
    Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1988 Oct; 31(2):305-11. PubMed ID: 3244707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats.
    Datla KP; Curzon G
    Eur J Pharmacol; 1997 Aug; 333(1):27-31. PubMed ID: 9311657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine.
    Fuxe K; Farnebo LO; Hamberger B; Ogren SO
    Postgrad Med J; 1975; 51 Suppl 1():35-45. PubMed ID: 1219678
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat.
    Weiss GF; Rogacki N; Fueg A; Buchen D; Leibowitz SF
    Brain Res Bull; 1990 Dec; 25(6):849-59. PubMed ID: 2289171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p-chloroamphetamine.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Sep; 35(9):597-8. PubMed ID: 6138413
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine.
    Rowland NE; Rokadia S; Green DJ; Robertson K
    Pharmacol Biochem Behav; 2004 Mar; 77(3):541-6. PubMed ID: 15006465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats.
    Fuller RW; Snoddy HD; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):202-5. PubMed ID: 622385
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors.
    Consolo S; Bertorelli R; Russi G; Zambelli M; Ladinsky H
    J Neurochem; 1994 Jun; 62(6):2254-61. PubMed ID: 8189232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons.
    Kalia M
    Brain Res; 1991 May; 548(1-2):111-25. PubMed ID: 1868326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regeneration of d,l-fenfluramine-destroyed serotonergic nerve terminals.
    Westphalen RI; Dodd PR
    Eur J Pharmacol; 1993 Jul; 238(2-3):399-402. PubMed ID: 8405109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of escalating doses of d-fenfluramine on the content of indoles in brain.
    Caccia S; Sarati S; Anelli M; Garattini S
    Neuropharmacology; 1992 Sep; 31(9):875-9. PubMed ID: 1436395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat.
    Molliver DC; Molliver ME
    Brain Res; 1990 Mar; 511(1):165-8. PubMed ID: 2331614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.